There are currently 343 clinical trials in Fort Worth, Texas looking for participants to engage in research studies. Trials are conducted at various facilities, including Cook Children's Medical Center, GSK Investigational Site, Cook Children's Medical Center - Fort Worth and UT Southwestern/Simmons Cancer Center-Fort Worth. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Study of INCB123667 in Subjects With Advanced Solid Tumors
Recruiting
This is an open-label, dose-escalation and dose-expansion study to determine the safety, tolerability, PK, pharmacodynamics, and preliminary efficacy of INCB123667 when administered as monotherapy at the RDE(s) in participants with selected advanced or metastatic solid tumors. Part 1A (dose escalation) will determine the recommended dose of INCB123667 for expansion (RDE) and the maximum tolerated dose (MTD). Part 1B (cohort dose expansion phase) will further explore antitumor activity of INCB123... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
12/26/2023
Locations: Texas Oncology-Fort Worth South Henderson, Fort Worth, Texas
Conditions: Solid Tumors
Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)
Recruiting
The objective of this study is to assess the efficacy, safety, and pharmacokinetics of NBI-921352 as adjunctive therapy for seizures in subjects with SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE).
Gender:
All
Ages:
Between 2 years and 21 years
Trial Updated:
12/21/2023
Locations: Cook Children's Medical Center, Fort Worth, Texas
Conditions: SCN8A Developmental and Epileptic Encephalopathy Syndrome
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Recruiting
The FLEX Registry will be implemented to operate as a large-scale, population based, prospective registry. All patients with stage I to III breast cancer who receive MammaPrint® and BluePrint testing on a primary breast tumor are eligible for entry into the FLEX Registry, which is intended to enable additional study arms at low incremental effort and cost. FLEX Registry will utilize an adaptive design, where additional targeted substudies and arms can be added after the initial study is opened.
Gender:
All
Ages:
18 years and above
Trial Updated:
12/20/2023
Locations: The Center for Cancer and Blood Disorders, Fort Worth, Texas
Conditions: Breast Cancer
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
Recruiting
The primary objectives of this study are to explore the therapeutic effect of eluxadoline in treating irritable bowel syndrome with diarrhea (IBS-D) in pediatric participants 6-17 years of age, to evaluate the pharmacokinetics of eluxadoline in pediatric participants with IBS-D, and to evaluate the safety and tolerability of eluxadoline in pediatric participants with IBS-D. Enrollment of 12-17 years old age group is closed, enrollment of the 6-11 years old age group will continue.
Gender:
All
Ages:
Between 6 years and 17 years
Trial Updated:
12/19/2023
Locations: Cook Children's Med. Center /ID# 237537, Fort Worth, Texas
Conditions: Irritable Bowel Syndrome
Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection
Recruiting
Prospective will be collected in a minimum of 300 patients presenting with an acquired segmental mandibular defect ≥ 4 cm secondary to OSSC removal and who require mandibular reconstruction.
Gender:
All
Ages:
18 years and above
Trial Updated:
12/14/2023
Locations: John Peter Smith Health Network, Fort Worth, Texas
Conditions: Mandibular Reconstruction, Segmental Mandibular Defects
Childhood Cancer Survivor Study
Recruiting
The Childhood Cancer Survivor Study (CCSS) will investigate the long-term effects of cancer and its associated therapies. A retrospective cohort study will be conducted through a multi-institutional collaboration, which will involve the identification and active follow-up of a cohort of approximately 50,000 survivors of cancer, diagnosed before 21 years of age, between 1970 and 1999 and 10,000 sibling controls. This project will study children and young adults exposed to specific therapeutic mod... Read More
Gender:
All
Ages:
All
Trial Updated:
12/11/2023
Locations: Cook Children's Medical Center, Fort Worth, Texas
Conditions: Cancer
Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations
Recruiting
Compared to the general population, individuals from underserved communities are more likely to receive low quality end-of-life care and unwanted, costly and burdensome treatments due in part to a lack of advance care planning (ACP; the process of discussing wishes for end-of-life care with loved ones/clinicians and documenting them in advance directives). This study will use existing, trusted, and respected social networks to evaluate two conversation-based tools intended to engage underserved... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
12/08/2023
Locations: Como Community Center, Fort Worth, Texas
Conditions: Advance Care Planning, Advance Directives, Terminal Illness, Chronic Illness, Communication
Parental Research on Interventions for Social Media
Recruiting
The prevalence of underage alcohol use continues to be a public health concern. Numerous studies have reported associations between teen drinking tendencies and parental attitudes and beliefs, parental awareness of teen drinking, parental monitoring and the quality of the parent-teen relationship and communication. The extensive work in this area has resulted in parent-based intervention (PBI) efforts to prevent or reduce adolescent alcohol use. Several independent studies have indicated that te... Read More
Gender:
All
Ages:
15 years and above
Trial Updated:
12/06/2023
Locations: University of North Texas Health Science Center, Fort Worth, Texas
Conditions: Underage Drinking
Heat Therapy, Functional Capacity, and Vascular Health in Older Adults
Recruiting
To test the hypothesis that home-based leg heat therapy improves functional capacity, vascular function, and exercise hyperemia in older adults.
Gender:
All
Ages:
Between 55 years and 80 years
Trial Updated:
12/06/2023
Locations: University of North Texas Health Science Center, Fort Worth, Texas
Conditions: Aging Well, Walking, Difficulty, Hyperemia
Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies
Recruiting
This study will assess the safety and efficacy of increasing doses of narazaciclib (ON 123300) in combination with the standard daily dose (2.5mg) of letrozole in patients with Recurrent Metastatic Low-grade Endometrioid Endometrial Cancer and other Gynecologic Malignancies.
Gender:
Female
Ages:
18 years and above
Trial Updated:
12/05/2023
Locations: Texas Oncology - Fort Worth Cancer Center, Fort Worth, Texas
Conditions: Endometrioid Endometrial Cancer
Empowering Students Project
Recruiting
The Empowering Students Project is an evaluation of the effectiveness of a psychoeducational program for adolescents, intended to help youth build healthy relationship skills while supporting positive socioemotional development and promoting successful transition to young adulthood.
Gender:
All
Ages:
23 years and below
Trial Updated:
11/29/2023
Locations: The Parenting Center, Fort Worth, Texas
Conditions: Relationship, Social
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)
Recruiting
A 52-Week, Multi-center, Open-label, Active Treatment Extension Study to Evaluate Safety and Tolerability of Once Daily, Oral Administration of Resmetirom (MGL-3196)
Gender:
All
Ages:
18 years and above
Trial Updated:
11/28/2023
Locations: Texas Digestive Disease Consultants, Fort Worth, Texas
Conditions: Non-Alcoholic Fatty Liver Disease